Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

ORKA

+ Watchlist+ Portfolio

Oruka Therapeutics, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$96.32
52-Week Range
$25.23 – $115.52
Market Cap
$6.49B
P/E (TTM)
—
EPS (TTM)
-2.12
Dividend Yield
0.00%
Advanced Metrics
Price/Book
5.39
PEG Ratio
—
Return on Equity
-18.12%
Return on Assets
-13.15%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
29.62
Debt/Equity
0.00
Total Debt
$2.93M
Free Cash Flow
$-91.81M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$5.58B

Market Snapshot

About

Oruka Therapeutics is a clinical-stage biotechnology company developing innovative biologics for chronic skin diseases. The company focuses on creating long-acting antibody therapies for conditions like plaque psoriasis and atopic dermatitis that require less frequent dosing than current treatments.